Insmed (INSM) Total Non-Current Liabilities (2010 - 2026)

Insmed's (INSM) quarterly Total Non-Current Liabilities came in at $1.4 billion in Q1 2026, down 9.96% year-on-year from $1.5 billion in Q1 2025, and down 10.17% quarter-over-quarter from $1.5 billion in Q4 2025.

Insmed (INSM) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Insmed's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 9.96% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 9.96% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 3.25% from the prior year.
  • Total Non-Current Liabilities fell to $1.4 billion in Q1 2026 per INSM's latest filing, from $1.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.6 billion in Q2 2024 and bottomed at $953.5 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $1.5 billion (2025), against an average of $1.4 billion.
  • Across the five-year window, Total Non-Current Liabilities surged 100.91% in 2022 and plunged 34.46% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $1.5 billion in 2022, then rose by 4.42% to $1.6 billion in 2023, then declined by 0.39% to $1.6 billion in 2024, then declined by 3.25% to $1.5 billion in 2025, then dropped by 10.17% to $1.4 billion in 2026.
  • Per Business Quant, the three latest INSM Total Non-Current Liabilities figures stand at $1.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 1.37 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.37 Bn
Dec 31, 2025 1.52 Bn
Sep 30, 2025 1.41 Bn
Jun 30, 2025 1.05 Bn
Mar 31, 2025 1.52 Bn
Dec 31, 2024 1.57 Bn
Sep 30, 2024 1.57 Bn
Jun 30, 2024 1.60 Bn
Mar 31, 2024 1.55 Bn
Dec 31, 2023 1.58 Bn
Sep 30, 2023 1.54 Bn
Jun 30, 2023 1.59 Bn
Mar 31, 2023 1.56 Bn
Dec 31, 2022 1.51 Bn
Sep 30, 2022 1.02 Bn
Jun 30, 2022 953.51 Mn
Mar 31, 2022 967.32 Mn
Dec 31, 2021 757.37 Mn
Sep 30, 2021 783.05 Mn
Jun 30, 2021 685.92 Mn